Concentrum Wealth Management lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,766 shares of the biopharmaceutical company’s stock after acquiring an additional 413 shares during the quarter. […]
Norden Group LLC grew its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 240.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,163 shares of the biopharmaceutical company’s stock after purchasing an additional 19,177 shares during the period. […]
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the recipient of unusually large options trading activity on Thursday. Investors bought 42,588 put options on the stock. This represents an increase of 240% compared to the average volume of 12,513 put options. Gilead Sciences Trading Down 2.3 % Shares of NASDAQ:GILD traded down $1.53 during […]
Gilead Sciences (NASDAQ:GILD – Free Report) had its price target decreased by UBS Group from $81.00 to $75.00 in a report issued on Wednesday, Benzinga reports. UBS Group currently has a neutral rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued reports about the company. Oppenheimer lowered their price objective on Gilead […]
Gilead Sciences, Inc (NASDAQ:GILD) Shares Purchased by HF Advisory Group LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.